Pfizer probably did more than any other company to help the world normalize from the pandemic, and it reaped a financial windfall from its twin Covid-19 franchise—the top-selling vaccine and the leadi...
Tag: LLY
LLY Stock Dives After A ‘Bump In The Road’ Shakes Its Newest Diabetes Med
Eli Lilly (LLY) experienced a “bump in the road” for its newest diabetes treatment, Mounjaro, an analyst said Thursday as LLY stock toppled. X Mounjaro sales came out to $279.2 million, mi...
Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.
Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t bouncing back anytime soon. With real...
It’s Pharma Time: Why Merck and Lilly Stock Are Buys, but not Pfizer.
My 2023 biotech outlook calls for continued momentum in name changes. I just need to figure out what the stocks will do. Last year, Respira Technologies became Qnovia. It’s run by a former tobacco exe...
LLY Stock Dives — Taking Novo, Sanofi With It — After Fake Twitter Account Promises Free Insulin
Elon Musk’s new pay-for-play verification system on Twitter shook pharmaceutical mainstay Eli Lilly (LLY) — leading LLY stock to skid Friday — after a fake account claimed “insulin is free...
An Alzheimer’s Drug’s Big Surprise: What It Means
Until this past week, there seemed to be no answers to the Alzheimer’s puzzle. The leading theory of the disease, that it was caused by a buildup of beta amyloid plaque in the brain, had been disprove...
UBS upgrades Eli Lilly declaring LLY is working on ‘the biggest drug ever’
UBS Group (SWX: UBSG), a global financial provider, upgraded Eli Lilly (NYSE: LLY) to buy from neutral on Tuesday, September 20. UBS analyst Navin Jacob updated the price target from the previous $335...
Novartis Will Cut 8,000 Jobs Under CEO’s Shake-Up Plan
Text size Vasant Narasimhan, CEO of Novartis. ERIC PIERMONT/AFP/Getty Images Pharmaceutical giant Novartis said Tuesday it will lay off more than 7% of its workforce, just a few months after CEO Vas N...
This dividend fund is down 3% vs. S&P’s 20% drop. Here are its top stock picks
By now even the most ardent tech and growth-stock enthusiasts realize the bull market is over. John Kornitzer’s approach to selecting high-quality stocks for the Buffalo Flexible Income Fund is one th...
Eli Lilly stock pulls back from record high after disclosing sales by largest shareholder
Shares of Eli Lilly & Co. LLY, -3.10% fell 4.0% in afternoon trading Tuesday, to pullback from the previous session’s record close, after the drug maker disclosed that its largest shareholde...
Stocks Are Ready for a Bounce Higher After S&P 500 Closes Above Bear Market
Text size Dreamstime The stock market came awfully close to finishing Friday in a bear market, at least 20% off its peak in early January. Many investors would like to see it get there so Wall Street ...
U.S. Stock Futures Poised for Lower Open on Monday
Stocks are poised to open lower on Monday. Michael Nagle/Bloomberg Text size Here’s what you need to know to navigate the markets today. • U.S. stocks are set to open Monday slightly down. On Sunday n...
Biogen’s Alzheimer’s Drug Aduhelm Has Another Shot at Success
Illustration by Elias Stein Text size Biogen ’s Alzheimer’s disease therapy, Aduhelm, has been a disappointment for the company since its Food and Drug Administration approval last spring, with early ...
14 dividend stocks that rose 100% or more in 5 years as the payouts doubled
In basketball, a double-double is a combination of at least 10 or more of the following in a game: points scored, rebounds, assists, blocked shots or steals. For dividend stocks, you might find a scre...